Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial".

Zou, Ziyuan; Lin, Shanshan; Li, Xun; Qi, Xiaolong

Zou, Ziyuan; Lin, Shanshan; Li, Xun; Qi, Xiaolong.

Afiliação

Zou Z; CHESS Frontier Center, The First Hospital of Lanzhou University, Lanzhou, China The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China School of Public Health, Southern Medical University, Guangzhou, China The Fifth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China CHESS Frontier Center, The First Hospital of Lanzhou University, Lanzhou, China.

Ann Surg ; 270(6): e95-e96, 2019 12.

Article em En | MEDLINE | ID: mdl-31567356

Assuntos

Hipertensão Portal; Somatostatina; Humanos; Transplantados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Somatostatina / Hipertensão Portal Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google